Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:16:50 UTC
Update Date2022-03-07 02:51:44 UTC
HMDB IDHMDB0014772
Secondary Accession Numbers
  • HMDB14772
Metabolite Identification
Common NameSulfacetamide
DescriptionSulfacetamide is only found in individuals that have used or taken this drug. It is an anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections. [PubChem]Sulfacetamide is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), an essential component for bacterial growth (according to the Woods-Fildes theory). The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
Structure
Data?1582753219
Synonyms
ValueSource
AcetosulfamineChEBI
N'-acetylsulfanilamideChEBI
N-((p-Aminophenyl)sulfonyl)acetamideChEBI
N-(p-Aminobenzenesulfonyl)acetamideChEBI
N-[(p-Aminophenyl)sulfonyl]acetamideChEBI
N-Acetyl-4-aminobenzenesulfonamideChEBI
N-AcetylsulfanilamideChEBI
N-SulfanilylacetamideChEBI
N-SulphanilylacetamideChEBI
N(1)-Acetyl-4-aminophenylsulfonamideChEBI
N(1)-AcetylsulfanilamideChEBI
p-AminobenzenesulfonacetamideChEBI
p-AminobenzenesulfonoacetamideChEBI
SulfacetamidaChEBI
SulfacetamidumChEBI
SulfanilazetamidChEBI
SulphacetamideChEBI
SulphacetamidumChEBI
AcetosulphamineGenerator
N'-acetylsulphanilamideGenerator
N-((p-Aminophenyl)sulphonyl)acetamideGenerator
N-(p-Aminobenzenesulphonyl)acetamideGenerator
N-[(p-Aminophenyl)sulphonyl]acetamideGenerator
N-Acetyl-4-aminobenzenesulphonamideGenerator
N-AcetylsulphanilamideGenerator
N(1)-Acetyl-4-aminophenylsulphonamideGenerator
N(1)-AcetylsulphanilamideGenerator
p-AminobenzenesulphonacetamideGenerator
p-AminobenzenesulphonoacetamideGenerator
SulphacetamidaGenerator
SulphanilazetamidGenerator
AK-sulfHMDB
Ceta sulfaHMDB
Monosodium salt, sulfacetamideHMDB
Sodium, sulfacetamideHMDB
Sulf-10HMDB
Sulfacetamida, colircusiHMDB
Sulfacetamide sodiumHMDB
Sulfacetamide, monosodium salt, anhydrousHMDB
SulfacylHMDB
SulfairHMDB
AcetoptHMDB
AlbucidHMDB
Belph 10HMDB
BlephHMDB
Sodium sulamydHMDB
Sulf 10HMDB
Sulfacetam, coliriocilinaHMDB
AcetylsulfanilamideHMDB
AntéborHMDB
Coliriocilina sulfacetamHMDB
AK sulfHMDB
Belph-10HMDB
CetamideHMDB
Colircusi sulfacetamidaHMDB
Isopto cetamideHMDB
Sulamyd, sodiumHMDB
Sulfacetamide monosodium saltHMDB
SulfacilHMDB
Chemical FormulaC8H10N2O3S
Average Molecular Weight214.242
Monoisotopic Molecular Weight214.041212886
IUPAC NameN-(4-aminobenzenesulfonyl)acetamide
Traditional Namesulfacetamide
CAS Registry Number144-80-9
SMILES
CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1
InChI Identifier
InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)
InChI KeySKIVFJLNDNKQPD-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBenzenesulfonamides
Direct ParentAminobenzenesulfonamides
Alternative Parents
Substituents
  • Aminobenzenesulfonamide
  • Benzenesulfonyl group
  • Aniline or substituted anilines
  • Organic sulfonic acid or derivatives
  • Organosulfonic acid or derivatives
  • Sulfonyl
  • Acetamide
  • Aminosulfonyl compound
  • Amino acid or derivatives
  • Carboxylic acid derivative
  • Organic oxide
  • Organopnictogen compound
  • Primary amine
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Amine
  • Carbonyl group
  • Organic oxygen compound
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting Point183 °CNot Available
Boiling PointNot AvailableNot Available
Water Solubility4.21 g/LNot Available
LogP-0.6Not Available
Experimental Chromatographic Properties

Experimental Collision Cross Sections

Adduct TypeData SourceCCS Value (Å2)Reference
[M+H]+Not Available146.916http://allccs.zhulab.cn/database/detail?ID=AllCCS00000814
Predicted Molecular Properties
PropertyValueSource
Water Solubility4.21 g/LALOGPS
logP0.15ALOGPS
logP-0.26ChemAxon
logS-1.7ALOGPS
pKa (Strongest Acidic)4.3ChemAxon
pKa (Strongest Basic)2.14ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area89.26 ŲChemAxon
Rotatable Bond Count1ChemAxon
Refractivity52.48 m³·mol⁻¹ChemAxon
Polarizability20.49 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+150.41931661259
DarkChem[M-H]-147.03131661259
DeepCCS[M+H]+145.39230932474
DeepCCS[M-H]-142.99630932474
DeepCCS[M-2H]-176.16430932474
DeepCCS[M+Na]+151.30430932474
AllCCS[M+H]+147.032859911
AllCCS[M+H-H2O]+143.132859911
AllCCS[M+NH4]+150.632859911
AllCCS[M+Na]+151.732859911
AllCCS[M-H]-142.732859911
AllCCS[M+Na-2H]-143.532859911
AllCCS[M+HCOO]-144.432859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
SulfacetamideCC(=O)NS(=O)(=O)C1=CC=C(N)C=C13663.7Standard polar33892256
SulfacetamideCC(=O)NS(=O)(=O)C1=CC=C(N)C=C12073.8Standard non polar33892256
SulfacetamideCC(=O)NS(=O)(=O)C1=CC=C(N)C=C12181.7Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Sulfacetamide,1TMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12354.3Semi standard non polar33892256
Sulfacetamide,1TMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12220.2Standard non polar33892256
Sulfacetamide,1TMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12872.9Standard polar33892256
Sulfacetamide,1TMS,isomer #2CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C12118.7Semi standard non polar33892256
Sulfacetamide,1TMS,isomer #2CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C12094.6Standard non polar33892256
Sulfacetamide,1TMS,isomer #2CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C13190.2Standard polar33892256
Sulfacetamide,2TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12236.4Semi standard non polar33892256
Sulfacetamide,2TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12259.3Standard non polar33892256
Sulfacetamide,2TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C12672.7Standard polar33892256
Sulfacetamide,2TMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12242.2Semi standard non polar33892256
Sulfacetamide,2TMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12338.2Standard non polar33892256
Sulfacetamide,2TMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12698.3Standard polar33892256
Sulfacetamide,3TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12165.0Semi standard non polar33892256
Sulfacetamide,3TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12411.0Standard non polar33892256
Sulfacetamide,3TMS,isomer #1CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C12563.8Standard polar33892256
Sulfacetamide,1TBDMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12597.5Semi standard non polar33892256
Sulfacetamide,1TBDMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12450.9Standard non polar33892256
Sulfacetamide,1TBDMS,isomer #1CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12923.8Standard polar33892256
Sulfacetamide,1TBDMS,isomer #2CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C12391.6Semi standard non polar33892256
Sulfacetamide,1TBDMS,isomer #2CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C12329.9Standard non polar33892256
Sulfacetamide,1TBDMS,isomer #2CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C13173.9Standard polar33892256
Sulfacetamide,2TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12788.4Semi standard non polar33892256
Sulfacetamide,2TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12732.1Standard non polar33892256
Sulfacetamide,2TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C12802.5Standard polar33892256
Sulfacetamide,2TBDMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C12771.3Semi standard non polar33892256
Sulfacetamide,2TBDMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C12806.4Standard non polar33892256
Sulfacetamide,2TBDMS,isomer #2CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C12772.1Standard polar33892256
Sulfacetamide,3TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C12963.0Semi standard non polar33892256
Sulfacetamide,3TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C13132.8Standard non polar33892256
Sulfacetamide,3TBDMS,isomer #1CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C12776.5Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Sulfacetamide GC-MS (Non-derivatized) - 70eV, Positivesplash10-0a4l-9810000000-3ed7ef5d2301b3bc79b42017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Sulfacetamide GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 90V, Negative-QTOFsplash10-004i-0900000000-e5b859bd275f0249f49b2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 45V, Negative-QTOFsplash10-004i-1900000000-bcd794de99dec3d4cd4c2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 30V, Negative-QTOFsplash10-004i-1900000000-dc03b60aac28b7eaf7112021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 75V, Negative-QTOFsplash10-004i-0900000000-bbee625a2449684059ed2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 60V, Negative-QTOFsplash10-004i-0900000000-05ff1f753704f25135722021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 15V, Negative-QTOFsplash10-004i-2900000000-308e3144b1be4d33d9762021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 90V, Positive-QTOFsplash10-02di-9100000000-4a8ff5ef6ebcc14cd2552021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 75V, Positive-QTOFsplash10-004i-9200000000-4cc7df804333c91fa3f12021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 15V, Positive-QTOFsplash10-0a4i-1900000000-b63a6ce5ca1fab8859c42021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 30V, Positive-QTOFsplash10-0a4i-3900000000-99d02203a7ffbd4085c32021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 60V, Positive-QTOFsplash10-004i-9300000000-2fbaf60f75bc6ea9869d2021-09-20HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Sulfacetamide 45V, Positive-QTOFsplash10-056r-9500000000-c80d95695c21e4bb506e2021-09-20HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 10V, Positive-QTOFsplash10-014i-0590000000-b5664e637cd01d75aa3a2016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 20V, Positive-QTOFsplash10-05mk-2920000000-7391f4416c0887f991972016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 40V, Positive-QTOFsplash10-00kf-9200000000-bc9a1ce621f8dc3dfb2d2016-08-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 10V, Negative-QTOFsplash10-03di-0190000000-35993b29960b01b1cce32016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 20V, Negative-QTOFsplash10-0229-1950000000-6034a93912c159eaa0bb2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 40V, Negative-QTOFsplash10-0006-9200000000-f0d12405f0b5fc85b36c2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 10V, Positive-QTOFsplash10-0a4i-0900000000-afdb935daec0bfdc7de62021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 20V, Positive-QTOFsplash10-0006-9000000000-39a4eab401ea01d03e3b2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 40V, Positive-QTOFsplash10-014l-9000000000-12dd58539d3995bd275c2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 10V, Negative-QTOFsplash10-03di-0290000000-58a06de4ad28117dbf132021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 20V, Negative-QTOFsplash10-03k9-1890000000-f99a02caa8c0b1c3cd2e2021-10-11Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Sulfacetamide 40V, Negative-QTOFsplash10-0006-9300000000-e4b5ebbe07e4cdf21bc32021-10-11Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00634 details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry DB00634 details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB00634
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID5129
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkSulfacetamide
METLIN IDNot Available
PubChem Compound5320
PDB IDNot Available
ChEBI ID63845
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Download (PDF)
General References
  1. Roth HW, Leimbeck R, Sonnenschein B, Anger CB, Weber S: [The effective antibacterial spectrum of sulfacetamide]. Klin Monbl Augenheilkd. 1992 Mar;200(3):182-6. [PubMed:1578876 ]
  2. Del Rosso JQ: Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. Cutis. 2004 Jan;73(1 Suppl):29-33. [PubMed:14959943 ]
  3. Hull CA, Johnson SM: A double-blind comparative study of sodium sulfacetamide lotion 10% versus selenium sulfide lotion 2.5% in the treatment of pityriasis (tinea) versicolor. Cutis. 2004 Jun;73(6):425-9. [PubMed:15224788 ]